Insider Trading: Osiris Therapeutics Inc (OSIR.OQ)

OSIR.OQ on NASDAQ Stock Exchange Global Market

14.56USD
24 Jul 2014
Price Change (% chg)

$-0.05 (-0.34%)
Prev Close
$14.61
Open
$14.67
Day's High
$14.67
Day's Low
$14.64
Volume
8,407
Avg. Vol
65,392
52-wk High
$27.39
52-wk Low
$10.07

Search Stocks
FRIEDLI PETER
Trading Date Type Shares Traded Price Shares Held
5 Feb 2014 Buy 10,000 $14.93 14,810,455
13 Aug 2013 Sell 432,390 $25.44 14,800,455
13 Aug 2013 Buy 1,000,000 $11.00 14,800,455
11 Feb 2013 Buy 10,000 $7.73 14,232,845
9 Dec 2012 Sell 50,000 $9.52 14,222,845
14 Nov 2012 Sell 625 $9.34 14,272,845

Institutional Holders

% Shares Owned: 39.14%
# of Holders: 89
Total Shares Held: 13,395,613
3 Mo. Net Change: -2,887
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 4
# Net Buyers: -1

Officers & Directors

Name Age Since Current Position

Peter Friedli

60 Chairman of the Board

Lode Debrabandere

49 2014 President, Chief Executive Officer, Director

Philip Jacoby

61 2010 Chief Financial Officer, Treasurer, Corporate Secretary

Alla Danilkovitch

2014 Vice President - Research & Development

Felix Gutzwiller

66 2003 Independent Director

Hans Klingemann

64 2012 Independent Director

Jay Moyes

60 2006 Independent Director

Aziz Ahmad

IR Contact
Search Stocks